Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.195
+0.035 (3.02%)
Nov 21, 2024, 12:53 PM EST - Market open
DRMA's stock price has decreased by -90.73% in the past year and price targets may not have had time to catch up.
Dermata Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$6.00
Upside
+402.09%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +402.09% | Aug 21, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $240 → $60 | Strong Buy | Maintains | $240 → $60 | +4,920.92% | Mar 23, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $3,360 | Strong Buy | Initiates | $3,360 | +281,071.55% | Sep 21, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates $2,160 | Strong Buy | Initiates | $2,160 | +180,653.14% | Sep 14, 2021 |